ARCHIVES

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

This article is from The Cancer Letter archive.

Vol. 26 No. 5 | May 30, 2003

Download PDF Visit The Full Archive

Related Articles

DuBois Succeeds Hait As AACR President, Jacks Is President-Elect.

April 18, 2008

Vitamin D Not Associated With Risk For Less Common Cancers, Study Finds

July 30, 2010

House Committee To Examine Personal Genetic Test Kits

May 21, 2010

NCAB Subcommittee Oks Concept Of Five Recompetitions

October 23, 1981

O’Neill Recounts Private Meeting To Increase Cancer Appropriations

May 3, 1991

Cancer Center Directors Contemplate the Role of Centers In the 21st Century

May 7, 1999